Arecor Therapeutics PLC (GB:AREC) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Arecor Therapeutics PLC, a biopharmaceutical company known for enhancing existing therapies to promote healthier lives, has successfully passed all resolutions at its Annual General Meeting. In addition to AGM updates, the company revealed that its Nominated Adviser and Joint Broker has undergone a name change to Panmure Liberum Limited after a corporate merger. Arecor continues to focus on developing its proprietary portfolio and partnering with major industry players through its Arestat™ technology platform.
For further insights into GB:AREC stock, check out TipRanks’ Stock Analysis page.